New EMBL/CRG Research Unit for Systems Biology launched today

Today the European Molecular Biology Laboratory (EMBL), the Centre for Genomic Regulation (CRG) and the Spanish Ministry for Education and Science (MEC) officially launch their new joint EMBL/CRG Research Unit in Systems Biology on the campus of the Barcelona Biomedical Research Park. The Spanish Ministry for Education and Science will fund the new unit with 12.7 million Euros over the next nine years.

The EMBL/CRG Research Unit will be dedicated to systems biology, an emerging area of biomedicine that focuses on understanding and engineering complex biological systems. Its research will draw on the expertise of various scientific disciplines and will span the entire range from molecules to cells. The five multidisciplinary groups making up the unit will work with a variety of research techniques, including RNA interference, biochemical networks and mouse development. Head of the new unit will be Luis Serrano, who currently coordinates the EMBL Structural and Computational Biology Unit in Heidelberg. "Systems biology is the future of biomedicine," says Serrano, "and in this new partnership we will combine theoretical and experimental approaches to better understand some of the key aspects of human health."

"Merging EMBL's expertise in computational biology with the CRG's knowhow in specific areas of genomics and proteomics will allow us to tackle some of the most challenging questions of systems biology," says Iain Mattaj, Director General of EMBL. "The EMBL/CRG Research Unit complements EMBL's network of research partnerships and underlines our commitment to serving all our member states."

EMBL closely collaborates with leading research organizations in its 19 member states and already maintains four other partnerships; the Partnership for Structural Biology in Grenoble, France, the Partnership with DESY in Hamburg and the Molecular Medicine Partnership Unit in Heidelberg, both in Germany, and the Partnership with the Sars Centre in Bergen, Nor

Contact: Anna-Lynn Wegener
European Molecular Biology Laboratory

Page: 1 2

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. Research shows skeleton to be endocrine organ
3. Research aims to identify markers for menopausal women at risk for deadly blood clot
4. Research team enlightens the reasons for severe blindness
5. Research teams uncover risk genes for multiple sclerosis
6. Research shows NPD1 protects a key component of vision
7. Researchers find pathway that controls cell size and division
8. Researchers watch antibiotics, bacteria meet at atomic level
9. Researchers discover gene responsible for Restless Legs Syndrome
10. Research study describes the role part of the brain plays in memory
11. NY Stem Cell Foundations 2nd Annual Translational Stem Cell Research Conference

Post Your Comments:

(Date:7/22/2020)... ... July 21, 2020 , ... ... and innovation in technology and compliance, announces a new solution to manage regulated ... ensure every layer of their technology stack complies with FDA and global regulations. ...
(Date:7/4/2020)... ... 2020 , ... Aesthetics Biomedical (ABM), a leading aesthetics product ... only the products and treatments developed, but also the dedicated team behind the ... brands built by ABM have received several honors already for 2020, each of ...
(Date:6/28/2020)... Switzerland (PRWEB) , ... June ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that it ... company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/18/2020)... ... 17, 2020 , ... dicentra , a leading Contract ... industries, is pleased to announce that Charles Galea has joined its clinical trials ... is an accomplished and results-driven sales executive with over 10 years of expertise ...
(Date:7/10/2020)... BALTIMORE (PRWEB) , ... July ... ... Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has ... This broader license allows PathSensors to move into the point-of-care diagnostic market, ...
(Date:7/10/2020)... ... 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will ... SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at the ...
Breaking Biology Technology:
Cached News: